Patent details

Basic Information

Publication number:

EP1125582

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP013000617

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Use of estrogen agonists / antagonists for the treatment of sexual dysfunction

French Title of Invention:

Utilisation d'agonistes ou d'antagonistes d'oestrogène pour le traitement des troubles sexuels

German Title of Invention:

Verwendung von Oestrogen-Agonisten oder -Antagonisten zur Behandlung von sexuellen Funktionsstörungen

SPC Number:

Dates

Filing date:

05/01/2001

Grant date:

02/08/2006

EP Publication Date:

02/08/2006

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

22/08/2001

EP B1 Publication Date:

02/08/2006

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

05/01/2009

Expiration date:

05/01/2021

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

05/01/2001

 

 

Name:

Pfizer Products Inc.

Address:

Eastern Point Road, Groton, Connecticut 06340, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

02/08/2006

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

Lee Andrew George, Pfizer Global R. & D.

Address:

United States (US)

2

Name:

Day Wesley Warren, Pfizer Global R. & D.

Address:

United States (US)

3

Name:

Thompson David Duane, Pfizer Global R. & D.

Address:

United States (US)

Priority

Priority Number:

175704 P

Priority Date:

12/01/2000

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/40;

Filing date	Document type	Number of pages